Global Coagulation Analyzer Market is valued approximately USD 3.03 billion in 2019 and is anticipated to grow with a healthy growth rate of more than 5.7 % over the forecast period 2020-2027. Coagulation Analyzers provide the measurement of blood platelet levels. The Clotting tests are used for hemostasis system diagnosis and new coagulometers are used to observe the expansion in blood plasma and blood clots in blood. Increasing incidences of blood clotting disorders along with Changing lifestyle which leads to factors such as Deficiency of Vitamin K, obesity, and smoking all lead to blood clotting resulting in demand for coagulation Analyzers. Further, increasing population base suffering from lifestyle associated disease, and chronic blood disorders and Cardiovascular diseases increase the demand for Coagulation Analyzers driving the market growth. As per the American Heart Association’s Circulation Journal Report Annual Statistics update issued in January 2019, 48% of the adults in the US have some form of CVD. Also, as per the European Heart network report 2017, Cardiovascular diseases cause 3.9 million deaths in Europe accounting for 45% of all the deaths. Also, rising awareness about these conditions is likely to expand the diagnostic rate and preventive care management, which is projected to substantially increase the testing volume driving the market growth. Furthermore, Growth in clinical laboratories and diagnostic centers have created a huge demand for coagulation analyzers market due to intensifying number of patients with blood clots. However, high cost and strict government regulations impedes the growth of the market over the forecast period of 2020-2027. Although, increased automation in the process presents a lucrative opportunity for the market.
The regional analysis of global Coagulation Analyzer market is considered for the key regions such as Asia Pacific, North America, Europe, Latin America and Rest of the World. North America is the leading/significant region across the world in terms of market share owing to the growing number of clinics and hospitals along with well established healthcare infrastructure in the region. Whereas, Asia-Pacific is also anticipated to exhibit highest growth rate / CAGR over the forecast period 2020-2027. Factors such as rising population and increasing prevalence of Cardiovascular and other chronic diseases would create lucrative growth prospects for the Coagulation Analyzer market across Asia-Pacific region.
Major market player included in this report are:
Siemens Healthineers AG
Thermo Fisher Scientific Inc.
Nihon Kohden Corporation
Maccura Biotechnology Co. Ltd.
Bio Group Medical System
The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming eight years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within each of the regions and countries involved in the study. Furthermore, the report also caters the detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, the report shall also incorporate available opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:
Prothrombin Time Testing (PT)
Activated Clotting Time Testing (ACT)
Activated Partial Thromboplastin Time Testing (APTT)
Platelet Function Tests
Anti-Factor XA Tests
Heparin & Protamine Dose-response Tests for ACT
Other Coagulation Tests
By End User:
Rest of the World
Furthermore, years considered for the study are as follows:
Historical year – 2017, 2018
Base year – 2019
Forecast period – 2020 to 2027
Target Audience of the Global Coagulation Analyzer Market in Market Study:
Key Consulting Companies & Advisors
Large, medium-sized, and small enterprises
Value-Added Resellers (VARs)
Third-party knowledge providers